Ching-Shih Chen is the Lucius A. Wing Chair of Cancer Research and Therapy at The Ohio State University. From 2003 to 2006, he held the Kimberly Professorship in the Ohio State College of Pharmacy, where he is a member of the Division of Medicinal Chemistry and Pharmacognosy. Dr. Chen’s research explores the pathways that govern cancer cell survival as targets for drug discovery and design. In 2010, his licensing of two new anti-cancer drugs to Arno Therapeutics Inc., the subsequent Investigational New Drug (IND) approval by the Food and Drug Administration for both agents, and the initiation of clinical trials at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute earned him an Ohio State Innovator of the Year award. He holds 15 U.S. patents, with 17 U.S. patents pending, and has close to 200 publications. His work is supported by over $1 million in annual extra-and intra-mural funding. Dr. Chen is a fellow of the American Association for the Advancement of Science, and Ohio State has honored him as a Distinguished University Scholar. He earned his Ph.D. at the University of Wisconsin.